Stocks / NASDAQ / PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc.

Our Opinion

PharmaCyte Biotech Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following press release that they use animals for product testing.

“The Chairman of our Medical and Scientific Advisory Board, Dr. Matthias Löhr, is overseeing the study. We will be using the same animal study model that Dr. Löhr used in the earlier study that showed promise.” Read the following article

Company Description

PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer and diabetes in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable non-metastatic pancreatic cancer, as well as diabetes. The company is developing therapies for pancreatic and other tumors, including encapsulated genetically modified living cells.  The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is based in Laguna Hills, California.

Company Website: https://pharmacyte.com